Cargando…
Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis
PURPOSE: Amifostine is a highly efficacious cytoprotectant when administered in vivo at high doses. However, at elevated doses, drug toxicity manifests for general, non-clinical radioprotective purposes. Various strategies have been developed to avoid toxic side-effects: The simplest is reducing the...
Autores principales: | Seed, Thomas M., Inal, Cynthia E., Singh, Vijay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133974/ https://www.ncbi.nlm.nih.gov/pubmed/24597748 http://dx.doi.org/10.3109/09553002.2014.899450 |
Ejemplares similares
-
THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY
por: Singh, Vijay K., et al.
Publicado: (2016) -
Normal tissue radioprotection by amifostine via Warburg-type effects
por: Koukourakis, Michael I., et al.
Publicado: (2016) -
Radioprotective role of amifostine on osteointegration of titanium implants in the tibia of rats
por: Aydemir Celep, Nevra, et al.
Publicado: (2023) -
Three-Dimensional Cell Metabolomics Deciphers the Anti-Angiogenic Properties of the Radioprotectant Amifostine
por: Katsila, Theodora, et al.
Publicado: (2021) -
Response of 5 hpf zebrafish embryos to low-dose microbeam protons
por: Choi, Viann Wing Yan, et al.
Publicado: (2014)